No More Frequent Pap Smears Needed for External Genital Warts
Women with external genital warts do not need more frequent Pap smear screening than women without warts, and should follow standard age-based cervical cancer screening guidelines. 111
Clear Guideline Recommendation
The CDC's Sexually Transmitted Diseases Treatment Guidelines explicitly state: "In the absence of other indications, women who have external genital warts do not need Pap tests more frequently than women who do not have warts." 111 This recommendation appears consistently across multiple iterations of these authoritative guidelines.
The Reasoning Behind This Recommendation
Different HPV Types, Different Risks
The key distinction is that external genital warts are caused by low-risk HPV types (primarily types 6 and 11), while cervical cancer is caused by high-risk HPV types (primarily types 16 and 18) 2. These are fundamentally different viral strains with different disease outcomes:
- Low-risk HPV 6 and 11: Cause 90% of genital warts but do not cause cervical cancer
- High-risk HPV 16 and 18: Cause cervical cancer but rarely cause visible warts
The presence of visible genital warts does not indicate increased risk for cervical dysplasia or cancer unless there is concurrent infection with high-risk HPV types.
Standard Screening Applies
Women with genital warts should follow routine cervical cancer screening guidelines 34:
- Ages 21-29: Pap test every 3 years (cytology alone)
- Ages 30-65: Either Pap test every 3 years OR co-testing (Pap + high-risk HPV) every 5 years
- Age 65+: May discontinue if adequate prior negative screening and no history of high-grade lesions
Important Caveats and Clinical Pitfalls
When More Frequent Screening IS Indicated
More frequent screening is appropriate when 14:
- Abnormal Pap results (ASC-US, LSIL, HSIL, etc.) - follow ASCCP guidelines regardless of wart status
- History of CIN 2 or higher - annual screening typically recommended
- Immunocompromised status (HIV, transplant recipients) - annual screening
- History of cervical cancer or in-utero DES exposure - individualized surveillance
The Multifocal Infection Consideration
While research shows that HPV infections are often multifocal (present in multiple genital sites including cervix, vulva, and urethra) 5, and that women with external warts may have higher rates of cervical HPV detection 6, this does not change screening recommendations. The standard screening intervals are designed to detect clinically significant cervical disease regardless of external wart presence.
Don't Confuse Screening with Evaluation
The guideline addresses screening frequency, not initial evaluation. When a woman presents with genital warts, appropriate clinical evaluation includes 78:
- Visual inspection of all genital areas
- Routine age-appropriate Pap screening (not accelerated)
- Screening for other STIs (coinfection is common)
- Patient education and counseling
Practical Implementation
Do not alter Pap screening intervals based solely on external genital warts. The 2021 STI Treatment Guidelines 999 continue to emphasize risk-based management for abnormal screening results, but the presence of external warts alone does not constitute a risk factor requiring modified screening.
The focus should be on treating the visible warts, providing appropriate counseling about HPV transmission and prevention, and ensuring the patient receives standard age-appropriate cervical cancer screening - nothing more, nothing less.